PDGF signalling controls age-dependent proliferation in pancreatic β-cells

Area of Science:

• Regenerative Biology
• Endocrinology
• Developmental Biology

Background:

• Pancreatic beta-cell replication is crucial for maintaining glucose homeostasis and declines with age.
• Understanding the mechanisms behind this decline is key to developing diabetes therapies.
• Platelet-derived growth factor receptor (Pdgfr) signaling is implicated in cell growth and development.

Purpose of the Study:

• To investigate the role of Pdgfr signaling in age-dependent beta-cell proliferation.
• To identify strategies for inducing beta-cell expansion for diabetes treatment.

Main Methods:

• Studied Pdgfr signaling in mouse and human pancreatic islets across different ages.
• Utilized conditional gene inactivation of Pdgfra in beta-cells.
• Examined the effects of targeted PDGFR-α activation on beta-cell proliferation and downstream signaling pathways (Erk1/2, Ezh2).

Main Results:

• Age-dependent decline in beta-cell Pdgfr levels correlated with reduced Ezh2 levels and proliferation.
• Beta-cell-specific Pdgfra inactivation impaired neonatal expansion and adult regeneration in mice.
• PDGFR-α activation in mouse beta-cells stimulated Erk1/2 phosphorylation and Ezh2-dependent beta-cell expansion.
• Juvenile human islets, but not adult ones, responded to PDGF-AA by increasing beta-cell proliferation.

Conclusions:

• Pdgfr signaling is a conserved regulator of age-dependent beta-cell proliferation.
• Targeting Pdgfr signaling presents a novel therapeutic strategy for inducing beta-cell expansion in diabetes.
• Age and developmental stage influence beta-cell responsiveness to PDGF signaling.